Published in Gut on November 01, 2003
Molecular cancer prevention: Current status and future directions. CA Cancer J Clin (2015) 0.86
Cyclin A2 and CDK2 as Novel Targets of Aspirin and Salicylic Acid: A Potential Role in Cancer Prevention. Mol Cancer Res (2015) 0.84
Progress report. Gut (2004) 0.75
Chromoendoscopy with a Standard-Resolution Colonoscope for Evaluation of Rectal Aberrant Crypt Foci. PLoS One (2016) 0.75
Aspirin: still learning about the wonder drug. Gut (2003) 0.75
Cancer statistics, 2002. CA Cancer J Clin (2002) 10.79
Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med (1994) 5.42
PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell (1999) 5.12
Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Heart (2001) 3.88
Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med (1998) 2.72
Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res (1991) 2.06
Chemoprevention of colorectal cancer. N Engl J Med (2000) 1.98
Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res (1994) 1.85
Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol (1991) 1.64
Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis (1993) 1.54
Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics. Cell Prolif (2000) 1.44
Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res (2001) 1.41
Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose. J Natl Cancer Inst (1997) 1.40
The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs). J Exp Med (1999) 1.39
Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. J Natl Cancer Inst (1993) 1.26
Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis (2000) 1.14
Aberrant crypt foci in human colons: distribution and histomorphologic characteristics. Hum Pathol (1998) 1.12
Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma. Life Sci (1998) 1.11
Histology of aberrant crypt foci in the human colon. Histopathology (1997) 1.10
Chemoprevention of gastrointestinal malignancies with nonsteroidal antiinflammatory drugs. Cancer (2002) 0.98
Preventive effect of fermented brown rice and rice bran against colon carcinogenesis in male F344 rats. Oncol Rep (2002) 0.96
Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon. Carcinogenesis (1999) 0.95
Review article: COX-2, prostanoids and colon cancer. Aliment Pharmacol Ther (2002) 0.94
Wheat germ extract inhibits experimental colon carcinogenesis in F-344 rats. Carcinogenesis (2001) 0.90
Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the non-steroidal anti-inflammatory drug nabumetone. Int J Cancer (2001) 0.88
Aspirin, but not sodium salicylate, indomethacin, or nabumetone, reversibly suppresses 1,2-dimethylhydrazine-induced colonic aberrant crypt foci in rats. Dig Dis Sci (1997) 0.86
The prevention of colorectal cancer by aspirin use. Biomed Pharmacother (1999) 0.85
Effect of aspirin on incidence and growth of aberrant crypt foci induced in the rat colon by 1,2-dimethylhydrazine. Cancer Lett (1994) 0.82
Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon. Int J Cancer (1995) 0.81
Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol (1999) 0.80
Energy restriction modulates the development of advanced preneoplastic lesions depending on the level of fat in the diet. Nutr Cancer (1999) 0.80
Chemopreventive effect of aspirin on growth of aberrant crypt foci in rats. Int J Colorectal Dis (1998) 0.79
Antiplatelet therapy in the elderly. Aspirin, ticlopidine-clopidogrel, and GPIIb/GPIIIa antagonists. Clin Geriatr Med (2001) 0.77
"Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol (1975) 7.61
Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res (1968) 7.53
"Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol (1975) 4.86
A microassay for cell-mediated immunity. Transplantation (1970) 4.29
Evolution of tumours and the impact of molecular oncology. Nature (1985) 4.24
Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol (1999) 3.96
Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proc Natl Acad Sci U S A (1966) 3.56
Selective cytotoxicity of peritoneal leucocytes for neoplastic cells. Cell Immunol (1973) 3.17
Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus. J Exp Med (1968) 3.01
Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75). Int J Cancer (1977) 2.66
Water-soluble contrast material has no therapeutic effect on postoperative small-bowel obstruction: results of a prospective, randomized clinical trial. Am J Surg (1996) 2.47
Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry (1999) 2.32
A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J Virol (1995) 2.28
External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Cancer J Sci Am (1997) 2.16
In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen. J Exp Med (1972) 2.13
Surface immunoglobulin-moieties on lymphoid cells. Exp Cell Res (1970) 2.09
Preoperative serum hCG level and intraoperative failure of laparoscopic linear salpingostomy for ectopic pregnancy. Obstet Gynecol (1998) 2.03
Search for host defenses in Burkitt lymphoma: membrane immunofluorescence tests on biopsies and tissue culture lines. Cancer Res (1967) 2.01
Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res (1993) 2.01
T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res (1993) 1.98
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int J Cancer (1976) 1.97
Bupivacaine wound instillation via an electronic patient-controlled analgesia device and a double-catheter system does not decrease postoperative pain or opioid requirements after major abdominal surgery. Anesth Analg (2001) 1.96
Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution. Proc Natl Acad Sci U S A (1977) 1.87
Growth and antigenic properties of a biopsy-derived Burkitt's lymphoma in thymus-less (nude) mice. Int J Cancer (1973) 1.80
Cell surface localized IgM-kappa immunoglobulin reactivity in a case of chronic lymphocytic leukaemia. Clin Exp Immunol (1970) 1.80
Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Proc Natl Acad Sci U S A (1987) 1.77
Treatment of acute colonic pseudo-obstruction with neostigmine. J Am Coll Surg (2000) 1.75
Reversion of tumorigenicity and decreased agarose clonability after EBV conversion of an IgH/myc translocation-carrying BL line. Int J Cancer (1989) 1.74
LATE INTESTINAL STENOSIS FOLLOWING STRANGULATED HERNIA. Ann Surg (1928) 1.72
Studies on cytotoxicity generated in human mixed lymphocyte cultures. II. Anti-K562 effectors are distinct from allospecific CTL and can be generated from NK-depleted T cells. J Immunol (1979) 1.71
The lymphocyte response to primary Moloney sarcoma virus tumors in BALB-c mice. Definition of the active subpopulations at different times after infection. J Exp Med (1973) 1.68
Adenocarcinoma arising from the gastrointestinal epithelium in benign cystic teratoma of the ovary. Gynecol Oncol (1998) 1.65
Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal. Neuropsychopharmacology (1997) 1.63
Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes. Curr Med Res Opin (2009) 1.62
Detection of cell surface antigens on monolayer cells. I. The application of immune adherence on a micro scale. Immunology (1970) 1.62
Variation of antigenic characteristics between different mouse lymphomas induced by the Moloney virus. J Natl Cancer Inst (1966) 1.61
Sensitivity and specificity of dipstick tests for rapid diagnosis of malaria in nonimmune travelers. J Clin Microbiol (1999) 1.59
Nephrotic syndrome after treatment with 5-aminosalicylic acid. Br Med J (Clin Res Ed) (1988) 1.59
Should peritoneal tears be routinely closed during laparoscopic total extraperitoneal repair of inguinal hernias? A reappraisal. Surg Endosc (2004) 1.59
Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol (2010) 1.59
Endoscopic sphincterotomy in patients with gallbladder in situ: the influence of periampullary duodenal diverticula. Surgery (1990) 1.55
Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. Urology (1996) 1.55
Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimens and tissue cultures. J Natl Cancer Inst (1967) 1.52
Conditioned tumorigenicity of activated oncogenes. Cancer Res (1986) 1.51
Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth. Int J Cancer (1987) 1.48
The use of a disposable laparoscopic trocar for the injection and safe evacuation of echinococcus cysts of the liver. Surg Gynecol Obstet (1993) 1.48
Staged primary closure of the abdominal wall in patients with abdominal compartment syndrome. J Trauma (2001) 1.48
Acute stress response and posttraumatic stress disorder in traffic accident victims: a one-year prospective, follow-up study. Am J Psychiatry (1999) 1.48
Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphcoytes. J Exp Med (1980) 1.48
Non-human primates: a model for tuberculosis research. Tuberculosis (Edinb) (2003) 1.47
Disappearance of the NK effect after explantation of lymphocytes and generation of similar nonspecific cytotoxicity correlated to the level of blastogenesis in activated cultures. J Immunol (1980) 1.47
Clinical and laboratory findings of spotted fever in Israeli children. Pediatr Infect Dis J (1989) 1.47
Studies on Murine Sarcoma Virus: antigenic characterization of Murine Sarcoma Virus induced tumor cells. Int J Cancer (1969) 1.47
Surgace IgM specificity on cells derived from a Burkitt's lymphoma. Lancet (1967) 1.46
Characteristics of new cell lines derived from Burkitt lymphomas. Cancer (1969) 1.46
Is apoptosis present in progression to chronic hypertensive heart failure? J Card Fail (2000) 1.45
A comparison between emergency and delayed endoscopic injection sclerotherapy of bleeding esophageal varices in nonalcoholic portal hypertension. J Clin Gastroenterol (1990) 1.45
Lymphocyte cytotoxicity against autologous tumour biopsy cells in humans. Int J Cancer (1977) 1.45
The effect of anesthesia type on needle localization breast biopsy: another point of view. Am J Surg (1996) 1.45
The forgotten indwelling ureteral stent: a urological dilemma. J Urol (1995) 1.43
Antitumor necrosis factor antibodies reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat. JPEN J Parenter Enteral Nutr (1995) 1.43
Concentration of virus from water by electro-osmosis and forced-flow electrophoresis. Prep Biochem (1971) 1.43
Immunoglobulin and glucose-6-phosphate dehydrogenase as markers of cellular origin in Burkitt lymphoma. J Exp Med (1973) 1.42
Paracecal hernia: a cause of intestinal obstruction. Dis Colon Rectum (1986) 1.41
Fluorometric quantitation of fluorescein-coupled antibodies attached to the cell membrane. Proc Natl Acad Sci U S A (1969) 1.40
How conservatively can postoperative small bowel obstruction be treated? Am J Surg (1993) 1.39
Does diurnal variation in blood pressure exist in CAPD patients? Nephrol Dial Transplant (1994) 1.39
Laparoscopic splenectomy for immune thrombocytopenic purpura. J Laparoendosc Surg (1996) 1.39
Treatment of hypertension by enalapril and hydrochlorothiazide separately and together: a multicenter study. Isr J Med Sci (1990) 1.38
The patient with asymptomatic advanced renal failure--obstructive uropathy caused by inflammatory abdominal aortic aneurysm. Nephrol Dial Transplant (1998) 1.38
Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. Proc Natl Acad Sci U S A (1986) 1.38
Treatment of Burkitt's lymphoma. Lancet (1968) 1.37
Synergistic or antgonistic effect of different antibody concentrations on in vitro lymphocyte cytotoxicity in the Moloney sarcoma virus system. J Exp Med (1972) 1.36
Group-specific human granulocyte antigens on a chronic myelogenous leukemia cell line with a Philadelphia chromosome marker. Blood (1977) 1.35
Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s). J Immunol (1975) 1.34
Selection of an immunoresistant Moloney lymphoma subline with decreased concentration of tumor-specific surface antigens. J Natl Cancer Inst (1968) 1.32
Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. Mol Psychiatry (2013) 1.30
Impact of thrombocytopenia on survival of baboons with genetically modified pig liver transplants: clinical relevance. Am J Transplant (2009) 1.29
Amino acid derangements in patients with sepsis: treatment with branched chain amino acid rich infusions. Ann Surg (1978) 1.29
Hypersensitivity reactions at tumor sites. Cancer Res (1969) 1.26
Complications of nephron sparing surgery for renal tumors. J Urol (1994) 1.24
Activated T cells in the synovial fluid of arthritic patients: characterization and comparison with in vitro activated human and murine T cells in cooperation with monocytes in cytotoxicity. J Immunol (1979) 1.24
Human tumour--lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumour cells. Int J Cancer (1977) 1.24
Human thyroglobulin and thyroid extract as specific stimulators of sensitized lymphocytes. J Clin Endocrinol Metab (1971) 1.22
Ultrasound imaging-guided noninvasive ultrasound thrombolysis: preclinical results. Circulation (2000) 1.20
Oncogene activation and tumor progression. Carcinogenesis (1984) 1.16
Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide. JPEN J Parenter Enteral Nutr (1993) 1.14
Experience with cardiopulmonary bypass and deep hypothermic circulatory arrest in the management of retroperitoneal tumors with large vena caval thrombi. Ann Surg (1990) 1.13
Temperature-sensitive micrometer-thick layers of hyaluronan grafted on microspheres. J Am Chem Soc (2006) 1.13
Listeria monocytogenes pericarditis in a chronically hemodialyzed patient. Am J Med Sci (1984) 1.12
Aberrant crypt foci in human colons: distribution and histomorphologic characteristics. Hum Pathol (1998) 1.12
Characterization of immunoglobulin structures from the surface of chronic lymphocytic leukemia cells. J Exp Med (1971) 1.12
Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients. Br J Cancer (2006) 1.12
Endogenous TGF-beta contributes to the induction of the EBV lytic cycle in two Burkitt lymphoma cell lines. Int J Cancer (1994) 1.12
Telomerase activity in ductal carcinoma in situ of the breast. Breast Cancer Res Treat (1999) 1.11
Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro. Cancer Immunol Immunother (1990) 1.11
Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockade. J Urol (1997) 1.11
Large granular lymphocytes inhibit the in vitro growth of autologous Epstein-Barr virus-infected B cells. Cell Immunol (1983) 1.11